Related Experiment Video
Updated: May 21, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
RNA-binding protein SAMD4A targets FGF2 to regulate cardiomyocyte lineage specification from human embryonic stem
Na Yi1,2,3, Han-Rui Wang1,2,3, Yu-Ping Zhu1,2,3
1State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
Insights
SAMD4A, an RNA-binding protein, is crucial for heart development. It regulates cardiomyocyte lineage commitment by controlling FGF2 expression and AKT signaling, offering insights into congenital heart disease therapies.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Molecular Mechanisms of Development
Background:
- RNA-binding proteins (RBPs) play vital roles in cardiac development.
- Many RBPs involved in heart development remain uncharacterized.
Purpose of the Study:
- To investigate the role of SAMD4A in cardiomyocyte lineage specification.
- To elucidate the molecular mechanisms by which SAMD4A influences cardiac development.
Main Methods:
- Utilized a human embryonic stem cell (hESC) differentiation model into cardiomyocytes.
- Generated SAMD4A-knockdown and SAMD4A-overexpressing hESC lines.
Main Results:
- SAMD4A expression increases during early heart development.
- SAMD4A suppression impairs hESC proliferation, cardiac mesoderm differentiation, and cardiomyocyte function.
- SAMD4A binds FGF2 mRNA, stabilizing it and enhancing translation, thus upregulating FGF2 and modulating AKT signaling.
- FGF2 supplementation rescues proliferation defects caused by SAMD4A absence.
Conclusions:
- SAMD4A is essential for cardiomyocyte lineage commitment via post-transcriptional regulation of FGF2 and AKT signaling modulation.
- This study highlights SAMD4A's role in cardiac organogenesis.
- Findings provide insights into heart development mechanisms and potential therapeutic strategies for congenital heart disease.
Background:
RNA-binding proteins (RBPs) are essential in cardiac development. However, a large of them have not been characterized during the process.
Methods:
We applied the human embryonic stem cells (hESCs) differentiated into cardiomyocytes model and constructed SAMD4A-knockdown/overexpression hESCs to investigate the role of SAMD4A in cardiomyocyte lineage specification.
Results:
SAMD4A, an RBP, exhibits increased expression during early heart development. Suppression of SAMD4A inhibits the proliferation of hESCs, impedes cardiac mesoderm differentiation, and impairs the function of hESC-derived cardiomyocytes. Correspondingly, forced expression of SAMD4A enhances proliferation and promotes cardiomyogenesis. Mechanistically, SAMD4A specifically binds to FGF2 via a specific CNGG/CNGGN motif, stabilizing its mRNA and enhancing translation, thereby upregulating FGF2 expression, which subsequently modulates the AKT signaling pathway and regulates cardiomyocyte lineage differentiation. Additionally, supplementation of FGF2 can rescue the proliferation defect of hESCs in the absence of SAMD4A.
Conclusions:
Our study demonstrates that SAMD4A orchestrates cardiomyocyte lineage commitment through the post-transcriptional regulation of FGF2 and modulation of AKT signaling. These findings not only underscore the essential role of SAMD4A in cardiac organogenesis, but also provide critical insights into the molecular mechanisms underlying heart development, thereby informing potential therapeutic strategies for congenital heart disease.
More Related Videos
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
10:46Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Published on: November 3, 2011
Related Concept Videos
Lineage Commitment
Master Transcription Regulators
Methods of Nuclear Reprogramming